Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Am J Addict. 2013 May;22(3):212–217. doi: 10.1111/j.1521-0391.2012.00327.x

Table 2.

Comparison of CP and SP groups on pain location, pain genesis, and pain-related substance usea

CP
(n = 88)
%
SP
(n = 87)
%
χ2 P AOR
(95% CI)
P
Pain location 35.6 <0.001
     Back 84 72 2.3 (0.9–5.3) 0.06
     Shoulder 33 20 2.9 (1.3–6.6) 0.01
     Pelvis 10 2 6.7 (1.1–39.9) 0.04
     Hands 9 3 4.3 (0.8–22.8) 0.08
     Feet 13 12 1.3 (0.4–4.2) 0.71
     Stomach 16 31 0.4 (0.1–0.9) 0.03
     Head 19 23 1.0 (0.4–2.6) 0.95
     Face 2 3 0.9 (0.1–9.5) 0.93
     Legs 48 47 1.4 (0.7–2.8) 0.42
     Arms 6 15 0.1 (0.03–0.5) 0.005
     Other 25 18 1.7 (0.7–3.9) 0.21

CP
(n = 88)
%
SP
(n = 87)
%
χ2 P AOR
(95% CI)
P

Pain genesis 48.2 <0.001
     Accident 57 25 6.2 (2.1–18.1) 0.001
     Surgery 11 6 1.8 (0.4–8.4) 0.45
     Nerve damage 21 2 15.7 (2.9–84.5) 0.001
     Arthritis 11 1 5.9 (0.5–67.3) 0.15
     HIV 0 0 -- --
     Cancer 0 0 -- --
     Don’t know 21 23 2.8 (0.8–9.5) 0.10
     Other 19 46 0.7 (0.2–2.2) 0.58

Pain-related Substance Use in Past Week 17.1 0.10
     More than prescribed opiate medication 33 18 1.5 (0.6–3.4) 0.35
     Somebody else’s opiate pain medication 61 45 1.6 (0.8–3.3) 0.19
     Heroin 39 33 1.1 (0.5–2.2) 0.88

CP
(n = 88)
%
SP
(n = 87)
%
χ2 P AOR
(95% CI)
P

     Street methadone 15 9 1.1 (0.4–3.2) 0.89
     More than prescribed non-opiate medication 11 3 2.0 (0.4–9.7) 0.38
     Somebody else’s non-opiate medication 13 7 0.9 (0.3–3.6) 0.95
     More than prescribed benzodiazepine medication 11 5 1.5 (0.3–7.0) 0.59
     Somebody else’s benzodiazepine medication 14 5 1.6 (0.3–7.3) 0.55
     Other street drugs 36 24 1.5 (0.6–3.5) 0.34
     Alcohol 24 25 0.5 (0.2–1.2) 0.13

CP = Chronic pain, SP = Some pain, AOR = Adjusted odds ratio.

a

Controlling for age.